Sema4 Looks to M&A After Successful SPAC

Sema4 Looks to M&A After Successful SPAC

Source: 
Medical Devices and Diagnostics Industry
snippet: 

Sema4 is acquiring Opko Health’s subsidiary, GeneDx, in a deal that could have a price tag of $623 million if milestones are added in. The acquisition is set to close in 2Q22.